Gerald J. Dal Pan

发表的论文31 篇，按出版时间

1. 1
   Physician Understanding and Perceptions of Risk Communication Related to Drugs Covered by Risk Evaluation and Mitigation Strategy ProgramsPharmacoepidemiology and Drug Safety20260
2. 2
   Communicating Drug Safety and Safe Use Conditions in Risk Evaluation and Mitigation Strategy MaterialsDrug Safety20260
3. 3
   A Plasmode Simulation‐Based Bias Analysis for Residual Confounding by Unmeasured Variables Leveraging Information‐Rich SubsetsPharmacoepidemiology and Drug Safety20261
4. 4
   Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) ToolDrug Safety20262
5. 5
   Physician Awareness of FDA’s Relaxation of REMS-Required Laboratory Testing Requirements and Changes in Prescribing Practices During the COVID-19 PandemicDrug Safety20260
6. 6
   Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational MaterialsDrug Safety20252
7. 7
   Dexamethasone Dose for COVID ‐19 in a Large U.S. Hospital Network From April 2020 to May 2023Pharmacoepidemiology and Drug Safety20240
8. 8
   Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000–2020Drug Safety20247
9. 9
   Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic StudyDrug Safety202411
10. 10
    When can real‐world data generate real‐world evidence?Pharmacoepidemiology and Drug Safety202318